Watch this on-demand Webcast featuring an expert presentation on the use of checkpoint inhibitors in patients with advanced hepatocellular carcinoma. This program specifically focuses on educating hepatologists, medical oncologists, and other members of the multidisciplinary care team.
In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.
In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, provide a succinct discussion of key considerations in the contemporary use of immune checkpoint inhibitors for treating patients with advanced hepatocellular carcinoma.
In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations for hepatologists, oncologists, and other HCPs in the contemporary use of immune checkpoint inhibitors for treating specific patient cases with advanced hepatocellular carcinoma.
In this downloadable PDF transcript from a CCO podcast, David Kaplan, MD, MSc, and Thomas Karasic, MD, discuss HCP questions focused on current best practices with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.
Download this slideset for multidisciplinary expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with advanced HCC.
Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with HCC.
Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions from a series of live CCO Webinars focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.
Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, as they provide a succinct discussion of key considerations in the contemporary use of immune checkpoint inhibitors for treating patients with advanced hepatocellular carcinoma.
Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations for hepatologists, oncologists, and other healthcare professionals in the contemporary use of immune checkpoint inhibitors for treating specific patient cases with advanced hepatocellular carcinoma.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.